Probiotics in the Treatment of Irritable Bowel Syndrome
- Registration Number
- NCT01837472
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Evidence have shown benefits of gut flora modulation in treatment of irritable bowel syndrome (IBS), but few reports are available on the effects of multistrain probiotics and there are few reports available in this regard from our society. Thus, we investigated if probiotics are effective in our patients as well. We hypothesize that the multistrain probiotic Balance containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains, and Streptococcus thermophiles reduces the symptoms of irritable bowel syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 132
- age between 18 and 65
- diagnosis of IBS based on the Rome III criteria
- willingness to participate
- receiving other probiotics compound during the study
- receiving antibiotics during the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo - Probiotic Probiotic -
- Primary Outcome Measures
Name Time Method Abdominal pain Up to 6 weeks Abdominal pain was assessed by Rome III questionnaire at baseline and then after 6 weeks
- Secondary Outcome Measures
Name Time Method Quality of Life Up to 6 weeks Quality of life was assessed by the IBS-QOL questionnaire at baseline and then after 6 weeks.
Trial Locations
- Locations (1)
Department of Gastroenterology, Alzahra Hospital
🇮🇷Isfahan, Iran, Islamic Republic of